Maria Manzano-Tristan

Pts
Granada, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Risk and Benefit Assessment of Gene Therapy with Lentiviral Vectors and Hematopoietic Stem Cells: The Skysona Case.

Risk and Benefit Assessment of Gene Therapy with Lentiviral Vectors and Hematopoietic Stem Cells: The Skysona Case.

Journal: Human gene therapy

Published: September 01, 2025

Tailoring CAR surface density and dynamics to improve CAR-T cell therapy.

Tailoring CAR surface density and dynamics to improve CAR-T cell therapy.

Journal: Journal for immunotherapy of cancer

Published: March 23, 2025

CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases?

CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases?

Journal: Frontiers in immunology

Published: September 27, 2024

Generating universal anti-CD19 CAR T cells with a defined memory phenotype by CRISPR/Cas9 editing and safety evaluation of the transcriptome.

Generating universal anti-CD19 CAR T cells with a defined memory phenotype by CRISPR/Cas9 editing and safety evaluation of the transcriptome.

Journal: Frontiers in immunology

Published: March 15, 2024

First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomas.

First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomas.

Journal: Molecular therapy. Nucleic acids

Published: February 26, 2024

Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells.

Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells.

Journal: Molecular therapy. Nucleic acids

Published: October 03, 2022

Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma.

Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma.

Journal: Frontiers in immunology

Published: August 04, 2022

Erratum: Physiological lentiviral vectors for the generation of improved CAR-T cells.

Erratum: Physiological lentiviral vectors for the generation of improved CAR-T cells.

Journal: Molecular therapy oncolytics

Published: August 03, 2022

Physiological lentiviral vectors for the generation of improved CAR-T cells.

Physiological lentiviral vectors for the generation of improved CAR-T cells.

Journal: Molecular therapy oncolytics

Published: November 15, 2021

Improved Functionality of Integration-Deficient Lentiviral Vectors (IDLVs) by the Inclusion of IS2 Protein Docks.

Improved Functionality of Integration-Deficient Lentiviral Vectors (IDLVs) by the Inclusion of IS2 Protein Docks.

Journal: Pharmaceutics

Published: July 09, 2021

Anti-CD44-Conjugated Olive Oil Liquid Nanocapsules for Targeting Pancreatic Cancer Stem Cells.

Anti-CD44-Conjugated Olive Oil Liquid Nanocapsules for Targeting Pancreatic Cancer Stem Cells.

Journal: Biomacromolecules

Published: March 16, 2021

Exosome: A New Player in Translational Nanomedicine.

Exosome: A New Player in Translational Nanomedicine.

Journal: Journal of clinical medicine

Published: June 23, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026